Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Mechanism of action of immune cells engagers. Immune cell engagers are ...
Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers ...
Superantigen-fused T cell engagers for tumor antigen-mediated robust T ...
Unlocking the potential of T cell engagers in solid tumors: Cancer Cell
Next-generation T cell engagers in oncology: Pharmacologic evolution ...
T cell Engagers and Beyond: A Promising Era of Targeted Immunotherapy ...
Frontiers | Natural killer cell engagers for cancer immunotherapy
ESMO 2024: T Cell Engagers in Prostate Cancer
T Cell Engagers in Primary Patient Samples – Viviabiotech
T Cell Engagers for Solid Tumors: What? How? Who? I’m happy to announce ...
Full article: Conditionally active T cell engagers for the treatment of ...
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger ...
Innovative strategies for T cell engagers for cancer immunotherapy - PubMed
Bispecific T cell engagers for cancer immunotherapy - PMC
Bispecific T Cell Engagers and Synthetic Immunity: Circumventing Immune ...
Transforming Immuno-Oncology Using Next-Generation Immune Cell Engagers
Taking T cell engagers to the next level
Proteomics for T Cell Engagers | Deep Profiling Cell Surface TAAs
Frontiers | Natural Killer Cell Engagers (NKCEs): a new frontier in ...
Immune Cell Engagers: Advancing Precision Immunotherapy for Cancer ...
Bispecific dendritic-T cell engager potentiates anti-tumor immunity: Cell
August 2025: Immune Cell Engagers: Next-Generation Immunotherapy
Bispecific Antibody-Based Immune-Cell Engagers in Cancer Immunotherapy ...
GSK’s $300M Acquisition of Chimagen’s CMG1A46: A Deep Dive into B Cell ...
Bispecific T-Cell Engagers for Cancer Immunotherapy
Week 2, May 2025: Multifunctional NKCEs (Natural Killer Cell Engagers)
Frontiers | Therapeutic approaches to enhance natural killer cell ...
T-Cell Engagers in Solid Cancers—Current Landscape and Future Directions
Development of bispecific T cell engagers: harnessing quantitative ...
Frontiers | Mechanistic insights into resistance mechanisms to T cell ...
Modular Design of T Cell Nanoengagers for Tumor Immunotherapy via ...
Frontiers | Advancements in γδT cell engineering: paving the way for ...
T-Cell Engagers in Solid Cancers—Current Landscape and Future ...
Emerging Bispecific T-Cell Engagers in Myeloma: Promises and Hurdles
Molecular Construction of T Cell Engagers: Formats Matter
For whom the T cells troll? Bispecific T-cell engagers in glioblastoma ...
The pre-existing T cell landscape determines the response to bispecific ...
T Cell Engagers: Revolutionizing Autoimmune Disease Treatment Infographic
Frontiers | Current landscape of T-cell engagers in early-phase ...
Bispecific T Cell Engager Assays | In Vitro Assays Services | WuXi ...
Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next ...
T-cell Engagers in Prostate Cancer - European Urology
Different formats of NK cell engagers. A BiKE molecule consisting of ...
Reactions and adverse events induced by T-cell engagers as anti-cancer ...
Minimising Toxicity and Maximising Response: T-Cell Engagers for ...
DARPin-fused T cell engager for adenovirus-mediated cancer therapy ...
Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell ...
Behind the paper: Chemical generation of checkpoint inhibitory T cell ...
Natural killer cell engagers: From bi‐specific to tri‐specific and ...
Concepts in immuno-oncology: tackling B cell malignancies with CD19 ...
CMS Cell and Gene Therapy (CGT) Access Model Explained
Figure 2 from Bispecific T-Cell Engagers and Chimeric Antigen Receptor ...
Construction of a bispecific T-cell engagers (BiTE) is shown in the ...
Frontiers | Perspective: Designing T-Cell Engagers With Better ...
T Cell Engagers: The Next Frontier in Cancer Therapy
T Cell Engagers: A Dual Breakthrough in Cancer and Autoimmune Therapy
Development of T-cell engagers selective for cells co-expressing two ...
Bispecific TCE Discovery & Development | Applications | WuXi Biologics
Bi-specific t-cell engager conceptual illustration. Bi-specific ...
Reimagining antibody-dependent cellular cytotoxicity in cancer: the ...
B7-H6/CD3 T-cell engager | InOncology – Boehringer Ingelheim
Redirecting innate cells to kill cancer
T-Cell Engager Therapy for Prostate Cancer: An Easy-to-Understand Guide ...
DLL3/CD3 T-cell Engager | Clinical Research | InOncology
T-cell engager targeting intracellular antigens
Schematic overview of the development of novel immune cell-based ...
Notes from the Lab: T-Cell Engagers, the Next Stage in Cancer ...
T-Cell Engagers—The Structure and Functional Principle and Application ...
T-Cell Engager Therapy in Prostate Cancer: Molecular Insights into a ...
Immunotherapy: R | Cancer immunotherapy: Pros, cons and beyond – KJOKRZ
Frontiers | Design of a Trispecific Checkpoint Inhibitor and Natural ...
PF-08046052
Conditionally active T-cell engager. Various approaches to ...
Frontiers | Engaging T cells for cleanup
Immunotherapy & Targeted Therapies, Cancer Treatment
Frontiers | Revolutionizing cancer treatment: the power of bi- and tri ...
Unlocking the Dark Genome | New Cancer Antigens for Next-Generation ...
Top Immunotherapy Trials in Head and Neck and Endocrine Cancers to ...
CD3‐T‐cell‐engager (TCE) therapies to overcome solid tumors: Beyond ...
Frontiers | Advancing Cancer Therapy with Present and Emerging Immuno ...
HBICE- Bi/Multi-specific - Nona Biosciences
Bispecific Antibody T-Cell Engager Therapy (BsAb) | Froedtert & MCW
LabGenius Debuts T-cell Engager Optimisation Capability That Yields ...
How a new type of T-cell engager could transform solid tumor treatment
Masked T-cell engagers: cancer immunotherapies for the future?
T-Cell Engagers: The Off-the-Shelf Alternative to CAR-T | TheraRadar
Robert Z. Orlowski: Nice review of tumor-intrinsic and -extrinsic ...
Disrupting B and T-cell collaboration in autoimmune disease: T-cell ...
Mechanism of action of bispecific T-cell engager antibody with ...
IL-7-primed bystander CD8 tumor-infiltrating lymphocytes optimize the ...
Beyond Antibodies and CAR-T: Topologically Engineered, Superdimeric ...
Platform – QLSF Biotherapeutics
Functional Validation of a Multispecific T-cell Engager in Acute ...
文献分享：一种新型T细胞衔接器双特异性抗体
